MUL-T-BOLT Trademark

Trademark Overview

On Monday, May 9, 2022, a trademark application was filed for MUL-T-BOLT with the United States Patent and Trademark Office. The USPTO has given the MUL-T-BOLT trademark a serial number of 97402103. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, September 4, 2024. This trademark is owned by Crossbow Therapeutics, Inc.. The MUL-T-BOLT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of cancer and immunological diseases; Medical and scientific research information in the field of cancer and immunological diseases; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the field of cancer and immunological diseases; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and immunological d...
mul-t-bolt

General Information

Serial Number97402103
Word MarkMUL-T-BOLT
Filing DateMonday, May 9, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2022

Trademark Statements

Pseudo MarkMULTIBOLT
Pseudo MarkMULTI BOLT
Pseudo MarkMUL T BOLT
Goods and ServicesMedical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of cancer and immunological diseases; Medical and scientific research information in the field of cancer and immunological diseases; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the field of cancer and immunological diseases; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and immunological diseases; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Consulting services in the field of pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 1, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCrossbow Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameCrossbow Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, May 12, 2022NEW APPLICATION ENTERED
Monday, May 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 1, 2022ASSIGNED TO EXAMINER
Monday, August 1, 2022NON-FINAL ACTION WRITTEN
Monday, August 1, 2022NON-FINAL ACTION E-MAILED
Monday, August 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 1, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, August 1, 2022EXAMINERS AMENDMENT E-MAILED
Monday, August 1, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 1, 2022EXAMINER'S AMENDMENT ENTERED
Monday, August 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 17, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 6, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 1, 2023SOU EXTENSION 1 FILED
Monday, June 5, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, June 5, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, June 15, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 15, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 25, 2023TEAS PETITION TO REVIVE RECEIVED
Sunday, June 25, 2023PETITION TO REVIVE-GRANTED
Sunday, June 25, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, June 26, 2023NOTICE OF REVIVAL - E-MAILED
Monday, August 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 8, 2023SOU EXTENSION 1 GRANTED
Wednesday, August 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 11, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 11, 2023SOU EXTENSION 2 FILED
Monday, September 11, 2023SOU EXTENSION 2 GRANTED
Wednesday, September 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 4, 2024ASSIGNED TO EXAMINER
Monday, March 4, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 4, 2024SOU EXTENSION 3 FILED
Monday, March 4, 2024SOU EXTENSION 3 GRANTED
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU EXTENSION 4 GRANTED
Wednesday, September 4, 2024SOU EXTENSION 4 FILED

Related Keywords

bolt research scientific medical field cancer diseases information development immunological providing